EUROPEAN MEDICAL SOLUTIONS
European Medical Solutions engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium and internationally. It offers R/F solutions, including PLATINUM NEO, a solution that revolutionizes the R/F workflow through an interface and AI-powered image processing; OPTIMA, a performance remote-controlled table designed to provid… Read more
EUROPEAN MEDICAL SOLUTIONS - Asset Resilience Ratio
EUROPEAN MEDICAL SOLUTIONS (ALEMS) has an Asset Resilience Ratio of 1.47% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2024)
This chart shows how EUROPEAN MEDICAL SOLUTIONS's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down EUROPEAN MEDICAL SOLUTIONS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €711.00K | 1.47% |
| Total Liquid Assets | €711.00K | 1.47% |
Asset Resilience Insights
- Limited Liquidity: EUROPEAN MEDICAL SOLUTIONS maintains only 1.47% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
EUROPEAN MEDICAL SOLUTIONS Industry Peers by Asset Resilience Ratio
Compare EUROPEAN MEDICAL SOLUTIONS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for EUROPEAN MEDICAL SOLUTIONS (2022–2024)
The table below shows the annual Asset Resilience Ratio data for EUROPEAN MEDICAL SOLUTIONS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.47% | €711.00K | €48.47 Million | -0.72pp |
| 2023-12-31 | 2.19% | €959.00K | €43.76 Million | +1.17pp |
| 2022-12-31 | 1.03% | €409.00K | €39.89 Million | -- |